These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 9002474)

  • 41. In vitro hepatic and skin metabolism of capsaicin.
    Chanda S; Bashir M; Babbar S; Koganti A; Bley K
    Drug Metab Dispos; 2008 Apr; 36(4):670-5. PubMed ID: 18180272
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition by capsaicin and its related vanilloids of compound action potentials in frog sciatic nerves.
    Tomohiro D; Mizuta K; Fujita T; Nishikubo Y; Kumamoto E
    Life Sci; 2013 Mar; 92(6-7):368-78. PubMed ID: 23352977
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Do partition coefficients (liphophilicity/hydrophilicity) predict effects of occlusion on percutaneous penetration in vitro: a retrospective review.
    Hafeez F; Maibach H
    Cutan Ocul Toxicol; 2013 Oct; 32(4):299-303. PubMed ID: 23535019
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Signaling mechanisms of down-regulation of voltage-activated Ca2+ channels by transient receptor potential vanilloid type 1 stimulation with olvanil in primary sensory neurons.
    Wu ZZ; Chen SR; Pan HL
    Neuroscience; 2006 Aug; 141(1):407-19. PubMed ID: 16678970
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Percutaneous penetration and absorption of parathion using human and pig skin models in vitro and human skin grafted onto nude mouse skin model in vivo.
    Boudry I; Blanck O; Cruz C; Blanck M; Vallet V; Bazire A; Capt A; Josse D; Lallement G
    J Appl Toxicol; 2008 Jul; 28(5):645-57. PubMed ID: 18041757
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Preparation and in vitro evaluations of topically applied capsaicin transfersomes].
    Long XY; Luo JB; Li LR; Lin D; Rong HS; Huang WM
    Zhongguo Zhong Yao Za Zhi; 2006 Jun; 31(12):981-4. PubMed ID: 17048643
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Evaluation of the hairless rat as a model for in vivo percutaneous absorption.
    Lauer AC; Elder JT; Weiner ND
    J Pharm Sci; 1997 Jan; 86(1):13-8. PubMed ID: 9002453
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of vehicle on the uptake and elimination kinetics of capsaicinoids in human skin in vivo.
    Pershing LK; Reilly CA; Corlett JL; Crouch DJ
    Toxicol Appl Pharmacol; 2004 Oct; 200(1):73-81. PubMed ID: 15451310
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Percutaneous absorption of nitroaromatic compounds: in vivo and in vitro studies in the human and monkey.
    Bronaugh RL; Maibach HI
    J Invest Dermatol; 1985 Mar; 84(3):180-3. PubMed ID: 3919108
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Methods for in vitro percutaneous absorption studies. VI: Preparation of the barrier layer.
    Bronaugh RL; Stewart RF
    J Pharm Sci; 1986 May; 75(5):487-91. PubMed ID: 3735088
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Maintenance of skin viability during in vitro percutaneous absorption/metabolism studies.
    Collier SW; Sheikh NM; Sakr A; Lichtin JL; Stewart RF; Bronaugh RL
    Toxicol Appl Pharmacol; 1989 Jul; 99(3):522-33. PubMed ID: 2749737
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Absorption of hydrophilic and lipophilic compounds through epidermal and subepidermal strata of rat skin in vitro.
    Pelling D; Phillips JC; Cunninghame ME
    Toxicol In Vitro; 1997 Jan; 12(1):47-55. PubMed ID: 20654388
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Percutaneous absorption on the relevance of in vitro data.
    Franz TJ
    J Invest Dermatol; 1975 Mar; 64(3):190-5. PubMed ID: 123263
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nonpungent N-AVAM Capsaicin Analogues and Cancer Therapy.
    Richbart SD; Friedman JR; Brown KC; Gadepalli RS; Miles SL; Rimoldi JM; Rankin GO; Valentovic MA; Tirona MT; Finch PT; Hess JA; Dasgupta P
    J Med Chem; 2021 Feb; 64(3):1346-1361. PubMed ID: 33508189
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Unravelling the mystery of capsaicin: a tool to understand and treat pain.
    O'Neill J; Brock C; Olesen AE; Andresen T; Nilsson M; Dickenson AH
    Pharmacol Rev; 2012 Oct; 64(4):939-71. PubMed ID: 23023032
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Formulation, characterization and pulmonary deposition of nebulized celecoxib encapsulated nanostructured lipid carriers.
    Patlolla RR; Chougule M; Patel AR; Jackson T; Tata PN; Singh M
    J Control Release; 2010 Jun; 144(2):233-41. PubMed ID: 20153385
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Suppression of central taste transmission by oral capsaicin.
    Simons CT; Boucher Y; Carstens E
    J Neurosci; 2003 Feb; 23(3):978-85. PubMed ID: 12574427
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Vanilloid receptor ligands: hopes and realities for the future.
    Szallasi A
    Drugs Aging; 2001; 18(8):561-73. PubMed ID: 11587243
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Percutaneous absorption of vanilloids: in vivo and in vitro studies.
    Kasting GB; Francis WR; Bowman LA; Kinnett GO
    J Pharm Sci; 1997 Jan; 86(1):142-6. PubMed ID: 9002474
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Kinetics of finite dose absorption through skin 1. Vanillylnonanamide.
    Kasting GB
    J Pharm Sci; 2001 Feb; 90(2):202-12. PubMed ID: 11169537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.